Preparation method and application of folacin mediated tumor targeting adriamycin prodrugs
The technology of a prodrug, doxorubicin, is applied in the preparation and application of folic acid-mediated tumor-targeting doxorubicin prodrug, which can solve the problems of cytotoxicity limitation, tumor cell drug resistance, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0036] Study on Antitumor Activity of Doxorubicin Prodrugs in Vitro
[0037] 1. Purpose:
[0038] The antitumor activity of the prodrug was evaluated by in vitro experiments with doxorubicin as a positive control.
[0039] 2 Research methods:
[0040] 2.1 In vitro cytotoxicity evaluation of prodrugs
[0041] Dissolve the various drugs to be tested in serum-free culture medium (DMSO less than 0.1%) according to the set concentration, and use 0.25% trypsin to digest KB cells with high expression of folic acid and folic acid in the logarithmic growth phase. Negatively expressed A549 cells were seeded in 96-well plates at a density of 1×10 4 After culturing for 24 hours, DOX, FA-AMA-DOX, and DOX-hyd-PEG-FA were added at 0.001, 0.01, 0.1, 1, and 10 μM (concentrations of doxorubicin) respectively (the culture medium without serum was blank Control), after incubation for 24h / 48h, add 20μL MTT and continue to incubate for 4h, discard the culture medium, redissolve the purple crys...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com